CLBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cellebrite DI Ltd (CLBT) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has demonstrated solid financial growth and strong demand for its products, the technical indicators and current price trend suggest bearish momentum. Additionally, there are no strong trading signals or significant catalysts to justify immediate entry.
The technical indicators show bearish momentum. The MACD is negatively expanding, RSI is neutral at 31.125, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 13.547, with resistance levels at 15.133 and 15.622.
Strong Q4 2025 financial performance with an 18% YoY revenue increase and 21% ARR growth.
Positive analyst commentary highlighting rising demand and AI as a growth driver.
Bearish technical indicators and price trend.
Market contraction leading to a lowered price target by TD Cowen.
Broader market weakness with the S&P 500 down 1.54%.
In Q4 2025, Cellebrite reported an 18% YoY revenue increase to $128.8 million, net income growth of 10.34% to $21.3 million, and a gross margin improvement to 84.71%. However, EPS remained flat at $0.08.
TD Cowen maintains a Buy rating but lowered the price target from $25 to $23 due to market contraction despite strong company execution and demand.
